Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab.

Lachno, D Richard

Validation of assays for measurement of amyloid-β peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab. [electronic resource] - Journal of Alzheimer's disease : JAD 2013 - 897-910 p. digital

Publication Type: Journal Article

1875-8908

10.3233/JAD-122317 doi


Alzheimer Disease--blood
Amyloid beta-Peptides--blood
Antibodies, Monoclonal, Humanized--therapeutic use
Antipsychotic Agents--therapeutic use
Biotinylation
Calibration
Enzyme-Linked Immunosorbent Assay
Female
Humans
Linear Models
Male
Peptide Fragments--blood
Reference Values
Reproducibility of Results
Time Factors